Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cancer Pain × Tapentadol × Clear all

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neuralgia 1 Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

Morphine 10 Methadone 6 Acetaminophen 5 Oxycodone 4 Lidocaine 4 Fentanyl 4 Ethanol 4 Transcutaneous Electric Nerve Stimulation 3 Buprenorphine 3 Acupuncture Therapy 3 Transcranial Direct Current Stimulation 2 Surveys and Questionnaires 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 oxycodone naloxone combination 1 nabiximols 1 incobotulinumtoxinA 1 Water 1 Tramadol 1 Therapeutic Touch 1 Telemedicine 1 Tapentadol 1 Sugars 1 Standard of Care 1 Ropivacaine 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡